首页> 外文会议>International Bhurban Conference on Applied Sciences and Technology >Serologic autoantibodies against tumor associated antigens as potential biomarkers in patients suffering from Hepatocellular carcinoma and Cholangiocarcinoma
【24h】

Serologic autoantibodies against tumor associated antigens as potential biomarkers in patients suffering from Hepatocellular carcinoma and Cholangiocarcinoma

机译:抗肿瘤相关抗原的血清自身抗体可作为肝细胞癌和胆管癌患者的潜在生物标志物

获取原文

摘要

Background: Hepatocellular carcinoma (HCC) and Cholangiocarcinoma (CC) are primary liver cancers. HCC develops in hepatocytes while CC originates from bile duct epithelium. Due to the lack of early diagnosis, the incidence of HCC and CC are ever increasing and providing effective therapy to the patients suffering from these cancers have increasingly become difficult. The significance of clinical diagnosis of HCC by the detection of tumor markers has not been well documented. So far, none of the studies that indicate the presence of specific autoantibodies in CC, on the contrary to HCC, has been reported. The aim of our current study is to identify new immunological tumor markers for the diagnosis of HCC and CC.Methods: In present study, we analyzed thirty three sera (28 male and 5 female, mean age = 62 years) from patients with HCC of different etiologies. Alcoholic (n=12), Hepatitis B virus infection (n=3), hepatitis C virus infection (n=8) and cryptogenic (n=IO). Six sera (3 male and 3 female, mean age= 51 years) from patients with cholangiocarcinoma (CC) and sera from healthy subjects (n=15). Sera were tested using immunoblots performed with nuclear, mitochondrial, microsomal and cytosolic proteins. SDS-PAGE resolved gels obtained from rat liver homogenate. Results: We have observed several autoantibodies (AAb) were seen on immunoblots performed both with microsomal and cytosolic fractions. AAb showing double bands of 54 kDa and 38 kDa microsomal proteins were found in 7 (21 %) and 3 (9%) HCC sera respectively. With cytosol as antigen, a 72 kDa band reacted with 8 (24%) HCC sera, and a 54 kDa band with 10 (30%) HCC sera. These AAbs were not detected in the sera of healthy controls. Concerning CC, we found two cytosolic proteins with molecular weights of 72-kDa and 54-kDa reacting only with the sera of 2 patients out of 6 CC sera, a 38-kDa microsomal protein stained by 2 sera and a 27kDa nuclear protein by only 1 patient serum. Conclusion: Here, we conclude that the protein specific autoantibodies in HCC and CC may be the future candidates for the diagnosis of these carcinomas and must be further characterized using appropriate methods.
机译:背景:肝细胞癌(HCC)和胆管癌(CC)是原发性肝癌。 HCC在肝细胞中发展,而CC起源于胆管上皮。由于缺乏早期诊断,HCC和CC的发病率不断增加,并且向患有这些癌症的患者提供有效的治疗变得越来越困难。通过检测肿瘤标志物临床诊断HCC的重要性尚未得到充分证明。迄今为止,还没有报道表明与肝癌相反,CC中存在特定自身抗体的研究。方法:在本研究中,我们分析了33例HCC患者的33份血清(男28例,女5例,平均年龄= 62岁)。不同的病因。酒精(n = 12),乙型肝炎病毒感染(n = 3),丙型肝炎病毒感染(n = 8)和隐源性(n = 10)。胆管癌(CC)患者的六份血清(3名男性和3名女性,平均年龄= 51岁)和健康受试者的血清(n = 15)。使用对核蛋白,线粒体蛋白,微粒体蛋白和胞质蛋白进行的免疫印迹检测血清。从大鼠肝脏匀浆中获得的SDS-PAGE解析凝胶。结果:我们观察到在用微粒体和胞质级分进行的免疫印迹中观察到了几种自身抗体(AAb)。分别在7(21%)和3(9%)HCC血清中发现显示54kDa和38kDa微粒体蛋白双条带的AAb。以溶质为抗原,一条72 kDa的条带与8(24%)HCC血清反应,一条54 kDa的条带与10(30%)HCC血清反应。在健康对照者的血清中未检测到这些AAb。关于CC,我们发现分子量分别为72-kDa和54-kDa的两种胞质蛋白仅与6个CC血清中的2个患者的血清反应,一个38-kDa的微粒体蛋白被2个血清染色,而一个27kDa的核蛋白仅被2个血清染色。 1名患者血清。结论:在这里,我们得出结论,肝癌和肝癌中的蛋白质特异性自身抗体可能是将来诊断这些癌症的候选药物,必须使用适当的方法对其进行进一步表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号